http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019376055-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcffd385b763387b8bc29b364cdd0f54
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2034-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2034-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00613
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B34-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B34-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N13-00
filingDate 2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2afb2e1ec1220339e3dbdb59793a7618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fe08a0204b2d2725ccbd676f5ceef39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ef2856a02385cc7d36588e8be524ce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c23ff115aa5fe637114f39a7f04c016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e707f9065e9974e5c51307c5d42a4e35
publicationDate 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019376055-A1
titleOfInvention Treatment planning for electroporation-based therapies
abstract The present invention provides systems, methods, and devices for electroporation-based therapies (EBTs). Embodiments provide patient-specific treatment protocols derived by the numerical modeling of 3D reconstructions of target tissue from images taken of the tissue, and optionally accounting for one or more of physical constraints or dynamic tissue properties. The present invention further relates to systems, methods, and devices for delivering bipolar electric pulses for irreversible electroporation exhibiting reduced or no damage to tissue typically associated with an EBT-induced excessive charge delivered to the tissue.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835314-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707629-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709502-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684408-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065047-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021242541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709891-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406820-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702326-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11738200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688305-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11655466-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497541-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959772-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382681-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11259869-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11272979-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11254926-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022098605-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357978-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311329-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11432871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11622803-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842572-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828086-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11589921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607271-B2
priorityDate 2008-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892

Total number of triples: 65.